Central sensitization syndrome refers to a group of chronic pain conditions believed to share a common biological driver: the nervous system itself becomes amplified, responding to stimuli more intensely than it should. Rather than a single disease, it is an umbrella term that links conditions like fibromyalgia, chronic fatigue syndrome, irritable bowel syndrome, migraine, and chronic low back pain under the idea that the brain and spinal cord have been rewired to produce and sustain pain even after an original injury has healed. The concept has gained traction over the past two decades as researchers have uncovered the specific neural changes that keep pain circuits stuck in overdrive, and it has reshaped how clinicians think about chronic pain that doesn’t respond to conventional treatments.
What Happens Inside the Nervous System
Under normal circumstances, pain signals travel from an injury site through nerves to the spinal cord’s dorsal horn, then up to the brain. The system dials itself up briefly to protect damaged tissue, then dials back down once healing is underway. In central sensitization, that dial-down never happens. Neurons in the spinal cord and brain become persistently hyperexcitable, firing more easily and more strongly in response to inputs that should be mild or even painless.1PubMed Central. Central sensitization: a generator of pain hypersensitivity by central neural plasticity
A key mechanism involves specific receptors on spinal cord neurons. When pain signals arrive repeatedly, these receptors become activated in a way that allows a flood of calcium into the cell, triggering a cascade of changes that make the neuron permanently more sensitive.2Frontiers in Pain Research. The Path to Discovery of Windup and Central Sensitization At the same time, the body’s built-in pain-dampening systems weaken. In migraine, for instance, the brain’s own pain-filtering circuits become impaired alongside the sensitization of pain-processing neurons, creating a double hit: more incoming signal, less ability to suppress it.3PubMed. General trigeminospinal central sensitization and impaired descending pain inhibitory controls contribute to migraine progression
The practical result is two hallmark symptoms. Hyperalgesia means a stimulus that should hurt a little now hurts a lot. Allodynia means something that shouldn’t hurt at all — a light touch on the skin, the brush of clothing — produces genuine pain. Both can be useful briefly after an injury, protecting vulnerable tissue, but when they persist without an active injury, they become the problem rather than the solution.4PubMed Central. Models and mechanisms of hyperalgesia and allodynia
The Role of Neuroinflammation
Sensitized neurons are not acting alone. Glial cells, the support cells of the nervous system, play a substantial role in keeping central sensitization going. When activated, these cells release inflammatory signaling molecules, including cytokines and chemokines, that act as powerful neuromodulators. Research shows that sustained elevation of these molecules in the central nervous system can produce widespread pain affecting multiple body sites, not just the area of the original problem.5PubMed Central. Neuroinflammation and Central Sensitization in Chronic and Widespread Pain
Different types of glial cells seem to contribute to different kinds of pain. Animal research suggests that microglia, one class of brain immune cell, are more involved in nerve-injury-related pain, while astrocytes, another class, contribute more to inflammatory pain.6PubMed Central. Contribution of microglia and astrocytes to the central sensitization, inflammatory and neuropathic pain in the juvenile rat This distinction matters because it hints at why different central sensitization conditions respond to different treatments, and why a single drug rarely addresses the full picture.
Which Conditions Fall Under the Umbrella
The term “central sensitivity syndromes” was proposed to group conditions that share overlapping symptoms, frequently co-occur in the same patients, and show laboratory evidence of central sensitization. A landmark analysis found that the concept holds up well: conditions within the group are mutually associated with each other at rates higher than chance, and several of them show direct evidence of altered central pain processing.7PubMed. Fibromyalgia and overlapping disorders: the unifying concept of central sensitivity syndromes The most commonly included conditions are:
- Fibromyalgia: widespread musculoskeletal pain with fatigue and cognitive difficulties
- Chronic fatigue syndrome: persistent exhaustion disproportionate to exertion
- Irritable bowel syndrome: recurrent abdominal pain with altered bowel habits
- Chronic migraine and tension-type headache: recurrent head pain that may become continuous
- Temporomandibular disorders: jaw pain often accompanied by headache and neck pain
- Chronic low back pain: particularly cases without a clear structural explanation
- Restless leg syndrome: uncomfortable sensations and urge to move the legs
Not every patient with one of these conditions has central sensitization, and central sensitization can exist in patients whose conditions don’t neatly fit any of these labels. The umbrella is a clinical framework, not a rigid diagnostic category, and its value lies in steering clinicians away from treating each symptom in isolation and toward addressing the shared mechanism driving them.
Risk Factors and the Weight of Early Life Stress
One of the strongest and most consistent risk factors for developing a central sensitivity syndrome is a history of childhood adversity. A large population-based study found that people who experienced childhood maltreatment had roughly double the risk of developing fibromyalgia and chronic low back pain, and about 80% higher risk for restless leg syndrome, compared to those without such histories.8The Lancet. Childhood maltreatment and the risk of developing central sensitivity syndromes: a population-based retrospective cohort study The association was not uniform across all conditions — temporomandibular disorder, chronic headache, and myofascial pain showed no significant link — but the combined risk of developing any somatic central sensitivity syndrome was about 40% higher in maltreated individuals.
The connection between early trauma and later sensitization appears to run through the nervous system itself. In adults with chronic pain who are taking opioids, higher levels of adverse childhood experiences predict higher scores on measures of central sensitization, along with greater depression, anxiety, and substance-use problems.9PubMed Central. Relationships among childhood trauma, central sensitization, and opioid-related risks in a community sample of adults with chronic pain on opioids This suggests early life stress can prime the nervous system in ways that make it more vulnerable to becoming sensitized later on, a finding that aligns with research on how stress hormones shape developing neural circuits.
Emerging epigenetic research is beginning to explain how those early experiences get biologically embedded. Studies have identified changes in DNA methylation and histone modifications at genes governing pain signaling, stress-hormone regulation, and neurotrophic factors like BDNF. These chemical marks on the genome don’t change the DNA sequence but can alter how genes are expressed, potentially tilting the nervous system toward a sensitized state for years or decades.10PubMed Central. Epigenetic mechanisms and therapeutic innovations in chronic pain-associated neuropsychiatric co-morbidities
Sex Differences in Central Sensitization
Women are disproportionately represented in nearly every central sensitivity syndrome. This is not just a reporting bias. Experimental studies in healthy people — with no pre-existing pain condition — show that central sensitization induction protocols produce a stronger response in women than in men, with larger increases in pain sensitivity at both the spinal cord and brain level.11PubMed Central. Healthy women show more experimentally induced central sensitization compared with men The researchers noted that the difference was even larger for subjective pain measures than for spinal reflex measures, suggesting that supraspinal processing — the brain’s interpretation of pain — amplifies the gap.
In clinical populations, this plays out clearly. Women with migraine, for example, report more allodynia, nausea, and sensitivity to odors than men with migraine, and also carry higher burdens of anxiety and depression. These patterns appear independent of hormonal cycles and likely reflect sex-specific genetic characteristics that influence how pain is processed.12PubMed. Sex Differences in the Expression of Central Sensitization Symptoms in Migraine: An Observational Study For clinicians, the takeaway is that women presenting with widespread or unexplained pain may warrant earlier screening for central sensitization, rather than waiting until multiple specialist referrals have been exhausted.
How Central Sensitization Is Assessed
There is no blood test or imaging scan that diagnoses central sensitization with certainty. The most widely used screening tool is the Central Sensitization Inventory (CSI), a self-report questionnaire with 25 items covering symptoms like sensitivity to light, difficulty concentrating, poor sleep, and pain that spreads across body regions. Research establishing the instrument found high reliability, and a score of 40 out of 100 was identified as the best cutoff for distinguishing patients with central sensitivity syndromes from those without them, with about 81% sensitivity and 75% specificity.13PubMed Central. The Central Sensitization Inventory (CSI): establishing clinically significant values for identifying central sensitivity syndromes in an outpatient chronic pain sample
The CSI has become a practical clinical tool, but it has limitations worth knowing about. It measures symptoms associated with central sensitization, not sensitization itself. A person can score above 40 because of overlapping conditions — severe anxiety and poor sleep, for example — without necessarily having sensitized spinal pathways. Clinicians often supplement the questionnaire with quantitative sensory testing, which applies controlled pressure, heat, or cold to the skin and measures how sensitively a person responds compared to norms. A finding of widespread lowered pain thresholds, or pain that spreads beyond the area being tested, adds confidence to the diagnosis.
What Brain Imaging Reveals
Brain scans have given researchers a window into the structural and functional changes associated with central sensitization. A systematic review of brain imaging in fibromyalgia found moderate evidence that patients show decreases in gray matter volume in specific regions, particularly the anterior cingulate cortex and prefrontal cortex, areas involved in attention, emotional regulation, and pain modulation. Overall brain volume, though, remains unchanged. Functional imaging showed that fibromyalgia patients activate the same pain-processing regions as healthy people but to a greater degree, consistent with the idea that the system’s gain is turned up. There was also evidence of reduced connectivity in the descending pain-modulating system, the circuit responsible for turning pain down.14Seminars in Arthritis and Rheumatism. Central sensitization in fibromyalgia? A systematic review on structural and functional brain MRI
Similar findings extend beyond fibromyalgia. In osteoarthritis patients, brain imaging showed significantly greater brainstem activation in response to stimulation of pain-referral areas, and the degree of activation correlated with how many neuropathic-like features the patient reported.15PubMed. Psychophysical and functional imaging evidence supporting the presence of central sensitization in a cohort of osteoarthritis patients This matters because osteoarthritis is often thought of as a purely structural, joint-wear-and-tear problem. Evidence of central sensitization in these patients helps explain why some people with mild joint damage on X-ray experience severe pain, and why joint replacement surgery sometimes fails to resolve it.
The Gut Connection
A growing body of research links gut health to central sensitization through the gut-brain axis. Changes in the composition of gut bacteria alter the production of metabolites like short-chain fatty acids and bile acids, which interact with receptors throughout the body. When this balance is disrupted, the resulting metabolites can increase the excitability of pain-sensing nerves directly, and they can also stimulate immune cells to release inflammatory molecules that cross the blood-brain barrier. Once in the brain, these molecules activate microglia, which then shift the balance of neurotransmitter signaling toward excitation and away from inhibition, reinforcing central sensitization.16PubMed Central. Oral and Gut Health, (Neuro) Inflammation, and Central Sensitization in Chronic Pain: A Narrative Review of Mechanisms, Treatment Opportunities, and Research Agenda
This pathway may partly explain the frequent overlap between irritable bowel syndrome and other central sensitization conditions. It also raises the question of whether interventions aimed at the gut microbiome — dietary changes, probiotics, or anti-inflammatory approaches — could influence central sensitization. The research here is still early-stage and mostly mechanistic, with few large clinical trials in humans. But the biological plausibility is strong enough that several research groups are pursuing it actively.
Autonomic Dysfunction and Long COVID
Central sensitization does not confine itself to pain. It overlaps substantially with autonomic nervous system dysfunction — the system that controls heart rate, blood pressure, digestion, and temperature regulation. A study of patients referred for autonomic testing found that 78% met criteria for central sensitivity syndromes. Those patients were younger, more often female, and had more severe autonomic symptoms. Objective testing showed lower levels of end-tidal carbon dioxide when standing and greater drops in cerebral blood flow velocity, indicating that central sensitization and autonomic dysregulation share overlapping biology.17PubMed Central. Role of Central Sensitization Syndrome in Patients With Autonomic Symptoms
This connection has taken on new relevance with long COVID, where many patients report a combination of pain, fatigue, brain fog, and autonomic symptoms like rapid heart rate on standing. Research suggests central sensitization is highly prevalent in long COVID patients and may contribute to their wide-ranging symptoms, with cerebral hypoperfusion and neuroinflammation as likely underlying mechanisms.18PubMed. Central sensitization in long COVID: Associations with autonomic symptom burden, cerebral hypoperfusion, and neuroinflammation For patients and clinicians alike, recognizing a central sensitization component in long COVID could redirect treatment away from chasing each symptom individually and toward addressing the amplified nervous system driving them all.
Treatment Approaches
Because central sensitization involves changes in the nervous system itself, standard painkillers that work at the site of an injury tend to be disappointing. Anti-inflammatory drugs, for instance, target peripheral inflammation that may no longer be the main pain generator. Instead, treatments need to reach the spinal cord and brain, and the most effective strategies usually combine several approaches.
On the medication side, drugs that modulate nerve signaling in the central nervous system show the most promise. Pregabalin, which dampens excitatory nerve signaling, has shown effectiveness in animal models of widespread sensitized pain, working even in the absence of ongoing tissue injury or nerve damage.19PubMed. Acetaminophen and pregabalin attenuate central sensitization in rodent models of nociplastic widespread pain Serotonin-norepinephrine reuptake inhibitors like duloxetine are also commonly prescribed because they strengthen the brain’s descending inhibitory pathways. Opioids, by contrast, are increasingly recognized as potentially counterproductive: chronic opioid use produces a neurobiological state resembling central sensitization itself, a phenomenon called opioid-induced hyperalgesia, and patients with higher central sensitization scores report more opioid-related problems including escalation of use and fear of pain-related relapse.20PubMed Central. Central sensitization in opioid use disorder: a novel application of the American College of Rheumatology Fibromyalgia Survey Criteria
Non-drug approaches have a strong evidence base. A randomized clinical trial tested a combination of pain neuroscience education — essentially teaching patients how their nervous system generates and amplifies pain — with cognition-targeted motor control training. Compared to standard physiotherapy, the combination produced lower central sensitization scores, less disability, and better quality of life, with improvements lasting at least 12 months.21JAMA Neurology. Effect of Pain Neuroscience Education Combined With Cognition-Targeted Motor Control Training on Chronic Spinal Pain: A Randomized Clinical Trial The idea that understanding pain can change how intensely you experience it sounds almost too simple, but it aligns with what we know about the brain’s role in pain amplification: changing expectations and beliefs genuinely alters neural processing.
Brain stimulation techniques like repetitive transcranial magnetic stimulation are being explored as well. An early study found that patients with high central sensitization scores responded to brain stimulation with improved pain thresholds, while those with low sensitization scores did not, suggesting the technique works best when there is an amplified central state to turn down.22PubMed Central. The Role of Central Sensitization in Responsiveness to Brain Stimulation for Patients with Nonspecific Chronic Low Back Pain – An Exploratory Study Virtual reality, cognitive behavioral therapy, and graded exercise programs are all under active investigation for their ability to target central sensitization through different routes, from modulating brain connectivity to restoring normal movement patterns.23The Egyptian Journal of Neurology, Psychiatry and Neurosurgery. Advances in targeting central sensitization and brain plasticity in chronic pain
Central Sensitization in Adolescents
Central sensitization is not limited to adults. Adolescents with hypermobility spectrum disorder and hypermobile Ehlers-Danlos syndrome show significantly lower pressure pain thresholds across multiple muscle groups compared to healthy peers, a pattern consistent with central sensitization.24PubMed Central. Exploring signs of central sensitization in adolescents with hypermobility Spectrum disorder or hypermobile Ehlers‐Danlos syndrome In the broader adolescent population, a prospective study found that self-reported symptoms of central sensitization in high school students predicted the development of chronic musculoskeletal pain six months later, with being female also a significant predictor.25Physical Therapy. The Onset of Chronic Musculoskeletal Pain in High School Adolescents: Associated Factors and the Role of Symptoms of Central Sensitization
These findings are concerning because adolescence is a period of rapid neural development, and the nervous system may be especially susceptible to sensitization during this window. A teenager whose pain signals become amplified early could carry that vulnerability into adulthood, making early identification and intervention potentially important for long-term outcomes. Yet screening for central sensitization in pediatric settings remains uncommon, partly because the tools were validated in adults and partly because widespread pain in teenagers is often dismissed as growing pains or stress. For parents and clinicians, persistent widespread pain in a young person — especially one with hypermobility or a history of adverse experiences — warrants consideration of central sensitization rather than a wait-and-see approach.